As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. But experts have concerns.

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS) inhibitors, starting an SGLT2 inhibitor was associated with a lower risk ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

One approach gaining traction is microdosing—consuming minimal amounts of cannabis to achieve desired outcomes while maintaining daily functionality. What is Microdosing Cannabis? Microdosing ...

(AP) – Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and ...

Semaglutide medications, like Ozempic and Wegovy, are more popular than ever. Millions of Americans have embraced them for ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

Please provide your email address to receive an email when new articles are posted on . The FDA did not approve the supplemental biologics license application for Eylea HD. The application would ...

"Microdosing" psychedelics, taking sub-perceptual doses of substances like LSD or psilocybin, has gone from fringe experimentation to mainstream obsession. Advocates claim benefits such as ...